---
title: "Products — fenbendazole for humans cancer 222mg - Flapen"
canonical_url: "https://flapen.com/research/us/patio-lawn-garden/fenbendazole-for-humans-cancer-222mg/products"
last_updated: "2026-08-06T13:54:04.631Z"
locale: en
meta:
  description: "Niche score 47/100 · $826K/yr market · 725K searches/yr · $40.10 avg price. Doesn't clear our bar today. Data updated Jul 2026."
  "og:description": "Niche score 47/100 · $826K/yr market · 725K searches/yr · $40.10 avg price. Doesn't clear our bar today. Data updated Jul 2026."
  "og:title": "Products — fenbendazole for humans cancer 222mg - Flapen"
---

# **fenbendazole for humans cancer 222mg**

**Skip it**

A concentrated shelf (top 5 take 86% of clicks) — this niche doesn't clear our bar today.

Market size 74Growth 18Conversion 36Competition 11Returns 97Price range 95Avg price 95Brand share 31Review moat 25Quality gap 42

**Returns**

**Incredible****0.7%**

return rate — above 5% kills the launch gate

**Avg price**

**Incredible****$40.10**

avg listing price — sweet spot $15–$100

**Price range**

**Incredible****$19.65–$84.81**

cheapest to priciest tracked listing — scored on the share inside $15–$100

**Market size**

**Good****$826K**

$826K/yr · 725K searches

**Quality gap**

**Okay****4.5★**

avg incumbent rating — lower means beatable quality

**Conversion**

**Okay****2.8%**

search→purchase rate — share of searches ending in a sale

**Brand share**

**Okay****86%**

top-5 brand share — brands hold most of the demand

**Review moat**

**Bad****4,283.89**

avg incumbent reviews — the moat a new listing must climb

**Growth**

**Bad****-13.9%**

90-day search growth — must beat 0% to launch

**Competition**

**Bad****86%**

top-5 click share — a locked-up shelf

**Signals**[** Low Review Barrier**](https://flapen.com/research/niches?market=us&signal=low_review_barrier "Top brand's reviews < 500")

## Products